RxDoctor Payments Data

Lesetta Weaver

Adult Health · Lancaster, PANPI 1750346763

Payments from drug & device makers

$578in general payments, 2019–2025

Across 26 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$129
  • Johnson & Johnson$101
  • Harmony Biosciences LLC$49
  • GSK$45
  • 3b Medical, Inc.$40
  • Regeneron Healthcare Solutions, Inc.$35
  • plus $178 from 8 others

What the payments were for

  • Food & beverage$55596%
  • Education$234%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$578 in reported general payments places this provider in the 55th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$38,993
Medicare patients
259
Services billed
365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter349$260,206
Breo ElliptaFluticasone/Vilanterol113$49,520
Spiriva RespimatTiotropium Bromide74$45,324
Stiolto RespimatTiotropium Br/Olodaterol Hcl57$30,453
Advair HfaFluticasone Propion/Salmeterol39$18,958
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$16,494
Fluticasone-SalmeterolFluticasone Propion/Salmeterol102$15,785
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate57$13,282
Combivent RespimatIpratropium/Albuterol Sulfate21$10,115
SymbicortBudesonide/Formoterol Fumarate42$10,011
Incruse ElliptaUmeclidinium Bromide24$8,727
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$7,629
Albuterol Sulfate HfaAlbuterol Sulfate219$6,062
DalirespRoflumilast11$4,318
Wixela InhubFluticasone Propion/Salmeterol18$3,221

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Anoro Ellipta, Arnuity Ellipta$45$329,249510 claims
AstraZenecaBreztri Aerosphere, Symbicort, Daliresp$129$30,82375 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 899 adult health providers in Pennsylvania.

Other adult health in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →